Concentrum Wealth Management’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,458
Closed -$130K 71
2024
Q1
$130K Sell
10,458
-10,540
-50% -$176K 0.06% 69
2023
Q4
$557K Buy
20,998
+5,230
+33% +$153K 0.29% 36
2023
Q3
$721K Buy
15,768
+212
+1% +$9.83K 0.44% 32
2023
Q2
$642K Buy
15,556
+360
+2% +$11.8K 0.41% 33
2023
Q1
$471K Sell
15,196
-5,765
-28% -$186K 0.35% 38
2022
Q4
$421K Sell
20,961
-520
-2% -$11.1K 0.38% 44
2022
Q3
$303K Buy
+21,481
New +$289K 0.26% 47

Other funds holding AEHR

Concentrum Wealth Management's AEHR Position: Q2 2024 in Review

Concentrum Wealth Management sold out of Aehr Test Systems (AEHR) in Q2 2024, closing a stake of 10,458 shares — an estimated $130K sold.

Concentrum Wealth Management first reported a position in AEHR in Q3 2022 and held it in 7 quarters. The position peaked at $721K in Q3 2023. 119 funds tracked by Wall St. Rank hold AEHR as of Q2 2024.

  • Concentrum Wealth Management reported no remaining Aehr Test Systems position as of Q2 2024 after selling out during the quarter.
  • Concentrum Wealth Management sold 10,458 Aehr Test Systems shares in Q2 2024, an estimated $130K.
  • Concentrum Wealth Management first reported a position in Aehr Test Systems in Q3 2022 and held it in 7 quarters.
  • Concentrum Wealth Management's Aehr Test Systems position peaked at $721K in Q3 2023.
  • 119 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2024.

Based on Concentrum Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.